This study is looking at whether a ketone supplement can help reduce opioid cravings and withdrawal symptoms for adults with opioid use disorder (OUD) who are starting inpatient withdrawal treatment. Researchers will compare the ketone supplement to a placebo (an inactive drink) to see if it helps with cravings, low mood, and pain. You might be able to join if you are 18-75 years old, have OUD, and are admitted for opioid withdrawal management at Caron Treatment Center. The main goal is to see if the ketone supplement can lower your craving for opioids. The study is currently unclear about its status and plans to enroll 50 participants.

Study design

This is an interventional study comparing a ketone supplement to a placebo in 50 participants. It is designed to see if the supplement can reduce opioid craving and withdrawal symptoms.

What's involved

You would receive either the ketone supplement or a placebo drink three times daily for seven days. You would also complete assessments for mood, pain tolerance, and opioid withdrawal.

Compensation

Not stated in the trial record.

Follow-up

Your craving levels will be measured at the beginning of the study and again on day 7.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.